[
    [
        {
            "time": "2018-08-14",
            "original_text": "智飞生物中报业绩增3倍 5家控股参股子公司支撑疫苗产业链布局",
            "features": {
                "keywords": [
                    "智飞生物",
                    "中报",
                    "业绩增长",
                    "疫苗",
                    "产业链"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物中报业绩增3倍 5家控股参股子公司支撑疫苗产业链布局",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-14",
            "original_text": "智飞生物（300122）2018年半年报点评：HPV疫苗放量，业绩迅猛增长",
            "features": {
                "keywords": [
                    "智飞生物",
                    "HPV疫苗",
                    "半年报",
                    "业绩增长"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物（300122）2018年半年报点评：HPV疫苗放量，业绩迅猛增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-08-14",
            "original_text": "自主及代理疫苗销售旺 智飞生物上半年盈利增三倍",
            "features": {
                "keywords": [
                    "智飞生物",
                    "疫苗销售",
                    "盈利增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "自主及代理疫苗销售旺 智飞生物上半年盈利增三倍",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-14",
            "original_text": "四价HPV半年卖262万支 智飞生物净利增297%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "四价HPV",
                    "净利增长"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "四价HPV半年卖262万支 智飞生物净利增297%",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-14",
            "original_text": "智飞生物上半年净利同比增约3倍 网红疫苗加持股价年内最高狂涨126%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "净利增长",
                    "网红疫苗",
                    "股价上涨"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物上半年净利同比增约3倍 网红疫苗加持股价年内最高狂涨126%",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 9,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-14",
            "original_text": "巨丰早参：A股纳入MSCI因子提高至5%",
            "features": {
                "keywords": [
                    "A股",
                    "MSCI因子",
                    "提高"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场整体"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "巨丰早参：A股纳入MSCI因子提高至5%",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 1,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-08-14",
            "original_text": "智飞生物：协议代理默沙东在国内上市在售的多个疫苗品种",
            "features": {
                "keywords": [
                    "智飞生物",
                    "默沙东",
                    "疫苗代理"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：协议代理默沙东在国内上市在售的多个疫苗品种",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-08-14",
            "original_text": "智飞生物：母牛分枝杆菌疫苗正式纳入特殊审批程序",
            "features": {
                "keywords": [
                    "智飞生物",
                    "母牛分枝杆菌疫苗",
                    "特殊审批"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：母牛分枝杆菌疫苗正式纳入特殊审批程序",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]